Resultados da busca - Jill S. Dolinsky
- Mostrando 1 - 20 resultados de 21
- Ir para a próxima página
-
1
-
2
-
3
-
4
Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing por Huma Q. Rana, Rebecca Gelman, Holly LaDuca, Rachel McFarland, Emily Dalton, Jennifer Thompson, Virginia Speare, Jill S. Dolinsky, Elizabeth Chao, Judy E. Garber
Publicado em 2018Artigo -
5
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results por Mary Pritzlaff, Pia Summerour, Rachel McFarland, Shuwei Li, Patrick Reineke, Jill S. Dolinsky, David E. Goldgar, Hermela Shimelis, Fergus J. Couch, Elizabeth Chao, Holly LaDuca
Publicado em 2016Artigo -
6
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls por Jenna Lilyquist, Holly LaDuca, Eric C. Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N. Hart, Jill S. Dolinsky, Fergus J. Couch, David E. Goldgar
Publicado em 2017Artigo -
7
Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar por Steven M. Harrison, Jill S. Dolinsky, Amy E. Knight Johnson, Tina Pesaran, Danielle R. Azzariti, Sherri J. Bale, Elizabeth Chao, Soma Das, Lisa M. Vincent, Heidi L. Rehm
Publicado em 2017Artigo -
8
Diagnosing hereditary cancer predisposition in men with prostate cancer por Mary Pritzlaff, Yuan Tian, Patrick Reineke, Aaron J. Stuenkel, Kyle Allen, Stephanie Gutierrez, Michelle Jackson, Jill S. Dolinsky, Holly LaDuca, Jianfeng Xu, Mary Helen Black, Brian T. Helfand
Publicado em 2020Artigo -
9
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients por Holly LaDuca, Aaron J. Stuenkel, Jill S. Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia‐Ling Gau, Erika Palmaer, Kamelia Shoaepour, Divya Shah, Virginia Speare, Stephanie Gandomi, Elizabeth Chao
Publicado em 2014Artigo -
10
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort por Chunling Hu, Eric C. Polley, Siddhartha Yadav, Jenna Lilyquist, Hermela Shimelis, Jie Na, Steven N. Hart, David E. Goldgar, Swati Shah, Tina Pesaran, Jill S. Dolinsky, Holly LaDuca, Fergus J. Couch
Publicado em 2020Artigo -
11
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes por Chunling Hu, Holly LaDuca, Hermela Shimelis, Eric C. Polley, Jenna Lilyquist, Steven N. Hart, Jie Na, Abigail Thomas, Kun Y. Lee, Brigette Tippin Davis, Mary Helen Black, Tina Pesaran, David E. Goldgar, Jill S. Dolinsky, Fergus J. Couch
Publicado em 2018Artigo -
12
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing por Hsiao‐Mei Lu, Shuwei Li, Mary Helen Black, Shela Lee, Robert Hoiness, Sitao Wu, Wenbo Mu, Robert Huether, Jefferey Chen, Srijani Sridhar, Yuan Tian, Rachel McFarland, Jill S. Dolinsky, Brigette Tippin Davis, Sharon Mexal, Charles Dunlop, Aaron Elliott
Publicado em 2018Artigo -
13
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer por Fergus J. Couch, Hermela Shimelis, Chunling Hu, Steven N. Hart, Eric C. Polley, Jie Na, Emily Hallberg, Raymond M. Moore, Abigail Thomas, Jenna Lilyquist, Bing Feng, Rachel McFarland, Tina Pesaran, Robert Huether, Holly LaDuca, Elizabeth Chao, David E. Goldgar, Jill S. Dolinsky
Publicado em 2017Artigo -
14
Somatic TP53 variants frequently confound germ-line testing results por Jeffrey N. Weitzel, Elizabeth Chao, Bita Nehoray, Lily R. Van Tongeren, Holly LaDuca, Kathleen R. Blazer, Thomas P. Slavin, Tina Pesaran, Christina Rybak, Ilana Solomon, Mariana Niell‐Swiller, Jill S. Dolinsky, Danielle Castillo, Aaron Elliott, Chia‐Ling Gau, Virginia Speare, Kory Jasperson
Publicado em 2017Editorial -
15
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk pa... por Holly LaDuca, Eric C. Polley, Amal Yussuf, Lily Hoang, Stephanie Gutierrez, Steven N. Hart, Siddhartha Yadav, Chunling Hu, Jie Na, David E. Goldgar, Kelly Fulk, Laura P. Smith, Carolyn Horton, Jessica Profato, Tina Pesaran, Chia-Ling Gau, Melissa Pronold, Brigette Tippin Davis, Elizabeth Chao, Fergus J. Couch, Jill S. Dolinsky
Publicado em 2019Artigo -
16
Suggested application of HER2+ breast tumor phenotype for germline <i>TP53</i> variant classification within ACMG/AMP guidelines por Cristina Fortuño, Jessica L. Mester, Tina Pesaran, Jeffrey N. Weitzel, Jill S. Dolinsky, Amal Yussuf, Kelly McGoldrick, Judy E. Garber, Sharon A. Savage, Payal P. Khincha, D. Gareth Evans, Maria Isabel Achatz, Kim E. Nichols, Kara N. Maxwell, Joshua D. Schiffman, Renata Lazari Sandoval, Paul A. James, Amanda B. Spurdle
Publicado em 2020Artigo -
17
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer por Rachid Karam, Blair R. Conner, Holly LaDuca, Kelly McGoldrick, Kate Krempely, Marcy E. Richardson, Heather Zimmermann, Stephanie Gutierrez, Patrick Reineke, Lily Hoang, Kyle Allen, Amal Yussuf, Suzette Farber-Katz, Huma Q. Rana, Samantha Culver, John Lee, Sarah Nashed, Deborah Toppmeyer, Debra L. Collins, Ginger Haynes, Tina Pesaran, Jill S. Dolinsky, Brigette Tippin Davis, Aaron Elliott, Elizabeth Chao
Publicado em 2019Artigo -
18
Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma por Randall E. Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B. Peters, Lindsey Stobie, Nathan Bahary, Herbert J. Zeh, Amer H. Zureikat, Melissa E. Hogg, Kenneth Lee, Allan Tsung, John C. Rhee, James Ohr, Weijing Sun, James Lee, A. James Moser, Kim DeLeonardis, Jill Krejdovsky, Emily Dalton, Holly LaDuca, Jill S. Dolinsky, Arlene Colvin, Cynthia Lim, Mary Helen Black, Nadine Tung
Publicado em 2018Artigo -
19
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing por Hermela Shimelis, Holly LaDuca, Chunling Hu, Steven N. Hart, Jie Na, Abigail Thomas, Margaret Akinhanmi, Raymond M. Moore, Hiltrud Brauch, Angela Cox, Diana Eccles, Amanda E. Toland, Peter A. Fasching, Florentia Fostira, Judy E. Garber, Andrew K. Godwin, Irene Konstantopoulou, Heli Nevanlinna, Priyanka Sharma, Drakoulis Yannoukakos, Song Yao, Bing Feng, Brigette Tippin Davis, Jenna Lilyquist, Tina Pesaran, David E. Goldgar, Eric C. Polley, Jill S. Dolinsky, Fergus J. Couch
Publicado em 2018Artigo -
20
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i> por Xin Yang, Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber, Judit Horváth, Karin Kast, Dieter Niederacher, Clare Turnbull, Richard S. Houlston, Helen Hanson, Chey Loveday, Jill S. Dolinsky, Holly LaDuca, Susan J. Ramus, Usha Menon, Adam N. Rosenthal, Ian Jacobs, Simon A. Gayther, Ed Dicks, Heli Nevanlinna, Kristiina Aittomäki, Liisa M. Pelttari, Hans Ehrencrona, Åke Borg, Anders Kvist, Bárbara Rivera, Thomas van Overeem Hansen, Malene Djursby, Andrew Lee, Joe Dennis, David D.L. Bowtell, Nadia Traficante, Orland Dı́ez, Judith Balmañà, Stephen B. Gruber, Georgia Chenevix‐Trench, kConFab Investigators, Allan Jensen, Susanne K. Kjær, Estrid Høgdall, Laurent Castéra, Judy E. Garber, Ramūnas Janavičius, Ana Osório, Lisa Golmard, Ana Vega, Fergus J. Couch, Mark E. Robson, Jacek Gronwald, Susan M. Domchek, Julie O. Culver, Miguel de la Hoya, Douglas F. Easton, William D. Foulkes, Marc Tischkowitz, Alfons Meindl, Rita K. Schmutzler, Paul D.P. Pharoah, Antonis C. Antoniou
Publicado em 2020Artigo
Ferramentas de busca:
Assuntos relacionados
Internal medicine
Medicine
Cancer
Biology
Oncology
Gene
Genetics
Genetic testing
Mutation
Breast cancer
Germline mutation
Germline
Genetic predisposition
Ovarian cancer
Colorectal cancer
Disease
Environmental health
PALB2
Population
Bioinformatics
CHEK2
DNA mismatch repair
Odds ratio
Family history
Lynch syndrome
Pancreatic cancer
Allele
Cohort
Exome sequencing
Genetic counseling